Evan W Newell Selected Research

Cytokines

8/2021	Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence.
1/2021	Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies.
1/2019	Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
11/2018	Dynamics of helper CD4 T cells during acute and stable allergic asthma.
10/2018	PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection.
2/2016	Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evan W Newell Research Topics

Disease

29	Neoplasms (Cancer) 04/2024 - 05/2002
16	Infections 11/2023 - 11/2014
8	Inflammation (Inflammations) 01/2023 - 01/2017
4	COVID-19 01/2023 - 10/2020
3	Human Influenza (Influenza) 10/2023 - 12/2013
3	Malaria 01/2023 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 01/2020
3	Persistent Infection 01/2020 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 03/2015 - 08/2013
2	Tuberculosis (Tuberculoses) 05/2024 - 03/2017
2	Virus Diseases (Viral Diseases) 10/2023 - 01/2018
2	Post-Acute COVID-19 Syndrome 01/2023 - 08/2021
2	Chronic Hepatitis B 10/2021 - 01/2020
2	Glioma (Gliomas) 01/2021 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
2	Lung Injury 11/2019 - 01/2019
2	Disease Progression 01/2019 - 10/2017
2	Narcolepsy 07/2014 - 12/2013
1	Leukemia 04/2024
1	Lymphoma (Lymphomas) 04/2024
1	Skin Neoplasms (Skin Cancer) 01/2024
1	Merkel Cell Carcinoma 01/2024
1	Multiple Myeloma 12/2023
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Diffuse Intrinsic Pontine Glioma 01/2023
1	Bites and Stings (Sting) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Convalescence 08/2021
1	Obesity 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Yellow Fever 01/2020
1	Epstein-Barr Virus Infections 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Dengue (Dengue Fever) 12/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Asthma (Bronchial Asthma) 11/2018

Drug/Important Bio-Agent (IBA)

16	AntigensIBA 05/2024 - 08/2013
10	EpitopesIBA 01/2023 - 12/2013
8	Peptides (Polypeptides)IBA 05/2024 - 03/2015
7	Proteins (Proteins, Gene)FDA Link 11/2023 - 12/2013
7	VaccinesIBA 01/2023 - 07/2013
6	CytokinesIBA 08/2021 - 02/2016
5	RNA (Ribonucleic Acid)IBA 04/2024 - 11/2018
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2017
4	Messenger RNA (mRNA)IBA 01/2023 - 05/2002
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	Neutralizing AntibodiesIBA 01/2021 - 10/2020
3	Antiviral Agents (Antivirals)IBA 01/2018 - 11/2014
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 01/2018
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2023 - 01/2019
2	ProteomeIBA 01/2023 - 10/2020
2	atezolizumabIBA 01/2022 - 12/2019
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 10/2018
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 05/2004
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2019 - 12/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2017
2	OrexinsIBA 07/2014 - 12/2013
1	H antigenIBA 04/2024
1	Programmed Cell Death 1 ReceptorIBA 03/2024
1	Oncogene Proteins (Oncogene Protein)IBA 02/2024
1	CalciumIBA 01/2023
1	Blood Proteins (Serum Proteins)IBA 01/2023
1	dipinacoline glutamateIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Viral ProteinsIBA 01/2023
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2023
1	InterferonsIBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	ChromatinIBA 08/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	NectinsIBA 01/2020
1	EnzymesIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Bacterial AntigensIBA 01/2020
1	Viral Envelope ProteinsIBA 01/2020
1	AntibodiesIBA 01/2020
1	Peptide LibraryIBA 01/2020
1	guanosine 5'-monophosphorothioateIBA 01/2020
1	LigandsIBA 01/2019
1	RezafunginIBA 11/2018
1	Immunoglobulin E (IgE)IBA 11/2018
1	Transcription Factors (Transcription Factor)IBA 11/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018
1	bemcentinibIBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Immune Checkpoint ProteinsIBA 01/2018
1	NivolumabIBA 01/2018

Therapy/Procedure

15	Therapeutics 04/2024 - 01/2016
11	Immunotherapy 04/2024 - 01/2018
2	Art Therapy 01/2023 - 02/2016
1	Hematopoietic Stem Cell Transplantation 04/2024
1	Investigational Therapies (Experimental Therapy) 01/2023
1	Intraperitoneal Injections 01/2020
1	Injections 01/2020
1	Immunomodulation 01/2018